IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway
Authors
Keywords
-
Journal
Clinical & Translational Oncology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-18
DOI
10.1007/s12094-021-02668-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of JAK/STAT signaling pathway and its inhibitors in diseases
- (2020) Ping Xin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Roles of IFN-γ in tumor progression and regression: a review
- (2020) Dragica Jorgovanovic et al. Biomarker Research
- Increased expression of IFN‑γ in preeclampsia impairs human trophoblast invasion via a SOCS1/JAK/STAT1 feedback loop
- (2020) Huiqiang Liu et al. Experimental and Therapeutic Medicine
- IL-17 promotes hepatocellular carcinoma through inhibiting apoptosis induced by IFN-γ
- (2019) Jie Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
- (2019) Katie L. Owen et al. Cancers
- Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
- (2019) Chin-Jui Wu et al. Cancers
- Maintenance treatment of recurrent ovarian cancer: Is it ready for prime time?
- (2018) Paul DiSilvestro et al. CANCER TREATMENT REVIEWS
- OCT4 accelerates tumorigenesis through activating JAK/STAT signaling in ovarian cancer side population cells
- (2018) Zhengyi Ruan et al. Cancer Management and Research
- The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion
- (2017) Marija Mojic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The untold story of IFN-γ in cancer biology
- (2016) M. Alper Kursunel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Increase of IFN-γ and TNF-γ production in CD107a + NK-92 cells co-cultured with cervical cancer cell lines pre-treated with the HO-1 inhibitor
- (2014) Paulina Gómez-Lomelí et al. Cancer Cell International
- SOCS signaling in autoimmune diseases: Molecular mechanisms and therapeutic implications
- (2014) Yan Liang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis
- (2014) Zhaoliang Su et al. IMMUNOLOGIC RESEARCH
- Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer
- (2014) W. Wen et al. MOLECULAR CANCER THERAPEUTICS
- SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation
- (2011) Carina Lindemann et al. ACTA NEUROPATHOLOGICA
- Division of labor by dual feedback regulators controls JAK2/STAT5 signaling over broad ligand range
- (2011) J. Bachmann et al. Molecular Systems Biology
- SOCS regulation of the JAK/STAT signalling pathway
- (2008) Ben A. Croker et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search